Health Payer Intelligence September 29, 2022
The payer will sell a minority stake in one of its subsidiaries to Penn Medicine, continuing the payer’s value-based care relationship with the health system.
Independence Blue Cross (Independence) announced that it will expand its value-based care relationship with Penn Medicine by selling a minority equity stake in one of Independence’s subsidiaries.
The payer will sell a minority stake in Tandigm Health to its health system partner. The goal is to empower the accessibility of Penn Medicine’s primary care services and also to provide new avenues for specialty care.
Specifically, Penn Medicine will work with Tandigm on the company’s value-based arrangements for primary care services with payers. The companies did not share a timeline for this agreement, but described...